Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
The American Journal of Medicine
|
June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
J C Wade, H C Standiford, G L Drusano, et al.
Drug Delivery
|
October 1, 2016
Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes
J T Sutton, K J Haworth, S K Shanmukhappa, et al.
The American Journal of Medicine
|
May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
C A De Jongh, J H Joshi, B W Thompson, et al.
The American Journal of Medicine
|
July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin
C A De Jongh, J C Wade, S C Schimpff, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
The American Journal of Medicine
|
June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
J C Wade, H C Standiford, G L Drusano, et al.
Drug Delivery
|
October 1, 2016
Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes
J T Sutton, K J Haworth, S K Shanmukhappa, et al.
The American Journal of Medicine
|
May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
C A De Jongh, J H Joshi, B W Thompson, et al.
The American Journal of Medicine
|
July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin
C A De Jongh, J C Wade, S C Schimpff, et al.
Page
of 5